CircMYBL2 promotes the EMT in breast cancer cells by sponging miR-1205, leading to the upregulation of the transcription factor E2F1, and by interacting with eukaryotic translation initiation factor 4A3 (eIF4A3) 58. Here, EIF4A3 is linked to breast cancer.